—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Summit Therapeutics PLC (SMMT) — Technical state

As of 2026-10-06 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

Recovery attempt under the 200-day

Trades +14% vs the 50-day and +5.8% vs the 200-day average, 40.8% below the 52-week high and +43.4% off the 52-week low; a death cross printed 73 sessions ago. Computed from daily closes.

The moving-average stack

Continue: the SMMT chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-10-06

Quick answers

What is the current Closelooknet signal on SMMT?

Recovery attempt under the 200-day — Trades +14% vs the 50-day and +5.8% vs the 200-day average, 40.8% below the 52-week high and +43.4% off the 52-week low; a death cross printed 73 sessions ago. Computed from daily closes. As of 2026-10-06; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is SMMT above its 50-day and 200-day moving averages?

As of 2026-10-06, Summit Therapeutics PLC trades +14% above its 50-day and +5.8% above its 200-day average, with the 20-day +1.8% away.

How far is SMMT from its 52-week high?

40.8% below the 52-week high and 43.4% above the 52-week low, as of 2026-10-06.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.